RN7SL787P

Across TCGA pan-cancer cohorts, RN7SL787P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL787P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RN7SL787P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL787P expression acts as an unfavorable survival marker.

OV, CHOL, and LUSC are the cancer types where RN7SL787P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.284	0.538	.002	72	view →
CHOL	OS	Tertile	All	0.512	0.728	.007	54	view →
LUSC	OS	Tertile	III,IV	0.147	0.664	.028	36	view →
HNSC	OS	Tertile	III,IV	0.059	0.674	<.001	36	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	24	view →
LGG	OS	Tertile	All	0.311	0.465	.003	21	view →
BLCA	DFS	Tertile	All	0.195	0.520	.036	18	view →
DLBC	OS	Tertile	IV	0.147	0.850	.002	18	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	18	view →
PAAD	OS	Tertile	II,III,IV	0.282	0.560	.012	18	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	12	view →
ESCA	DFS	Tertile	All	0.359	0.529	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL787P–OV (DFS)

Open the OV breakdown →